Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
A 3.5 angstrom resolution electron density map of the HIV-1 reverse transcriptase heterodimer complexed with nevirapine, a drug with potential for treatment of AIDS, reveals an asymmetric dimer. The polymerase (pol) domain of the 66-kilodalton subunit has a large cleft analogous to that of the Klenow fragment of Escherichia coli DNA polymerase I. However, the 51-kilodalton subunit of identical sequence has no such cleft because the four subdomains of the pol domain occupy completely different relative positions. Two of the four pol subdomains appear to be structurally related to subdomains of the Klenow fragment, including one containing the catalytic site. The subdomain that appears likely to bind the template strand at the pol active site has a different structure in the two polymerases. Duplex A-form RNA-DNA hybrid can be model-built into the cleft that runs between the ribonuclease H and pol active sites. Nevirapine is almost completely buried in a pocket near but not overlapping with the pol active site. Residues whose mutation results in drug resistance have been approximately located.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the connection domain lacks any catalytic site and has α–helices on only one side of the β–sheet (Figure 2a), compared to the RNH and IN domains (Figure 2b and 2c, respectively) [14].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“The mature, functional form of HIV-1 RT is a heterodimer, comprising 66 kDa and 51 kDa subunits (Figure 1b)”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“the connection domain directly interacts with nucleic acids via positively charged side chains to help heterodimer formation and possibly position the substrate in the RNH active site [14,15].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
Citations
Cites
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Self-citationResolution of phase ambiguity in macromolecular crystallography
Wang, B.-C. (1985) · Methods in Enzymology · doi:10.1016/0076-6879(85)15009-3 · Cited by 1,028
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP
Ollis, D. L., Brick, P., Hamlin, R., Xuong, N. G., & Steitz, T. A. (1985) · Nature · doi:10.1038/313762a0 · Cited by 848
Self-citationWeiss, R. A., & Bernstein, A. (1982) · Cold Spring Harbor Laboratory eBooks · Cited by 828
Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 808
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Research works printed but not linked: 2
- Kohlstaedt, L. A., Proceedings of the National Academy of Sciences of the United States of America 89: 9652 (1992).
- VARMUS, H, REVERSE TRANSCRIPTION, SCIENTIFIC AMERICAN 257: 56 (1987).
Cited by
Items 901–1,000 of 1,005
Small Molecule Inhibitors Targeting HIV‐1 Reverse Transcriptase Dimerization
Grohmann, D., Corradi, V., Elbasyouny, M., Baude, A., Horenkamp, F. A., Laufer, S. D., Manetti, F., Botta, M., & Restle, T. (2008) · ChemBioChem · doi:10.1002/cbic.200700669 · Cited by 30
Betancor, G., Puertas, M. C., Nevot, M., Garriga, C., Martínez, M. Á., Martínez‐Picado, J., & Menéndez‐Arias, L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00716-10 · Cited by 33
“HIV-1 RT is a heterodimer composed of 66- and 51-kDa subunits, with subdomains termed fingers, thumb, palm, and connection in both subunits and an RNase H domain in the large subunit only (23, 26, 29).”
BackgroundAnti-Tumor Activity of Non-Nucleosidic Reverse Transcriptase Inhibitors
Landriscina, M., Spadafora, C., Cignarelli, M., & Barone, C. A. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780249191 · Cited by 32
“This crucial event is catalyzed by a viral RT, a multifunctional enzyme made up of two subunits of 66 and 51 kDa, respectively, and endowed with both RNA- and DNAdependent DNA polymerase activity, and with an endonuclease that degrades the RNA-DNA intermediates formed during proviral synthesis [6].”
BackgroundAg, M., Nk, G., De Bishnu, P., & Banerjee, A. K. (2002) · Europe PMC (PubMed Central) · Cited by 30
Avidan, O., Entin‐Meer, M., Iris, O. Z., & Hizi, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02719.x · Cited by 35
“As RT is a preferred target for the development of viral inhibitors as antiretroviral drugs, the structural and catalytic properties of RTs have been the focus of many recent studies, including three-dimensional crystal studies [6–9].”
BackgroundOperario, D. J., Reynolds, H. M., & Kim, B. (2005) · Virology · doi:10.1016/j.virol.2005.02.010 · Cited by 38
Olivares, I., Sánchez-Merino, V., Martínez, M. Á., Domingo, E., López‐Galíndez, C., & Menéndez‐Arias, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6293-6298.1999 · Cited by 33
“The crystallographic structure of HIV-1 RT has been determined in the absence of ligands (28), complexed with nonnucleoside RT inhibitors (15), and complexed with double-stranded DNA (13).”
BackgroundBavand, M. R., Wagner, R., & Richmond, T. J. (1993) · Biochemistry · doi:10.1021/bi00091a003 · Cited by 30
Laco, G. S., & Beachy, R. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2654 · Cited by 30
Molecular dynamics of HIV‐1 reverse transcriptase indicates increased flexibility upon DNA binding
Madrid, M., Lukin, J. A., Madura, J. D., Ding, J., & Arnold, E. (2001) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.1137 · Cited by 34
“Moreover, proposed mechanisms of inhibition by NNRTIs include the possibility that the bound inhibitor may modify the mobility of the p66 thumb subdomain by altering a hinge between the p66 thumb and palm subdomains.(3) Although this model cannot explain all of the biochemical data, the inhibition of RT by NNRTIs may…”
BackgroundCushman, M., Casimiro‐Garcia, A., Hejchman, E., Ruell, J. A., Huang, M., Schaeffer, C. A., Williamson, K., Rice, W. G., & Buckheit, R. W. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9800595 · Cited by 30
Hannongbua, S., Pungpo, P., Limtrakul, J. P., & Wolschann, P. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008013917905 · Cited by 30
Klarmann, G. J., Smith, R. A., Schinazi, R. F., North, T. W., & Preston, B. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.359 · Cited by 36
Kew, Y., Qingbin, S., & Prasad, V. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36610-3 · Cited by 32
RNase H Cleavage of tRNAProMediated by M-MuLV and HIV-1 Reverse Transcriptases
Smith, C. M., Potts, W. B., Smith, J. S., & Roth, M. J. (1997) · Virology · doi:10.1006/viro.1997.8454 · Cited by 32
The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides
Volkmann, S., Dannull, J., & Moelling, K. (1993) · Biochimie · doi:10.1016/0300-9084(93)90027-p · Cited by 30
Artymiuk, P. J., Grindley, H. M., Kumar, K., Rice, D. W., & Willett, P. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81523-3 · Cited by 30
Ding, J., Jacobo‐Molina, A., Tantillo, C., Lu, X., Nanni, R. G., & Arnold, E. (1994) · Journal of Molecular Recognition · doi:10.1002/jmr.300070212 · Cited by 27
Zheng, X., Pedersen, L. C., Gabel, S. A., Mueller, G. A., Cuneo, M. J., DeRose, E. F., Krahn, J. M., & London, R. E. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku143 · Cited by 31
Looney, D. J., Ma, A., & Johns, S. T. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_440 · Cited by 42
“NNRTIs are non-competitive inhibitors of the reverse transcriptase enzyme (Mao et al. 2000; Crauwels et al. 2012; Kohlstaedt et al. 1992; Pollard et al. 1998; Smerdon et al. 1994).”
BackgroundInouye, S., Hsu, M.-Y., Xu, A., & Inouye, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31236 · Cited by 30
Ribas, J. C., & Wickner, R. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9306 · Cited by 29
The E249K Mutator Mutant of DNA Polymerase β Extends Mispaired Termini
Kosa, J. L., & Sweasy, J. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35866 · Cited by 29
Targeting the protein–protein interactions of the HIV lifecycle
Tavassoli, A. (2010) · Chemical Society Reviews · doi:10.1039/c0cs00092b · Cited by 41
Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
Famiglini, V., & Silvestri, R. (2016) · Molecules · doi:10.3390/molecules21020221 · Cited by 29
“The NNRTIs bind to a common allosteric site of the RT, the non-nucleoside binding site (NNBS), that is a hydrophobic pocket located just 10 Å from the DNA polymerase active site, formed by residues Leu100, Lys101, Lys103, Val106, Thr107, Val108, Val179, Tyr181, Tyr188, Val189, Gly190, Phe227, Trp229, Leu234, Pro236 an…”
BackgroundComplementary DNA Libraries: An Overview
Ying, S. (2004) · Molecular Biotechnology · doi:10.1385/mb:27:3:245 · Cited by 54
Ehteshami, M., & Götte, M. (2008) · PubMed · Cited by 28
3′-Azido-3′-deoxythymidine-resistant Mutants of DNA Polymerase β Identified by in Vivo Selection
Kosa, J. L., & Sweasy, J. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3851 · Cited by 29
Clark, A. D., Jacobo‐Molina, A., Clark, P. K., Hughes, S. H., & Arnold, E. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)62017-6 · Cited by 29
Pandey, P. K., Kaushik, N., Singh, K., Sharma, B., Upadhyay, A. K., Kumar, S., Harris, D., & Pandey, V. N. (2002) · BMC Biochemistry · doi:10.1186/1471-2091-3-18 · Cited by 29
Petrella, M., BRENNER, B. G., Loemba, H., & Wainberg, M. A. (2001) · Drug Resistance Updates · doi:10.1054/drup.2002.0235 · Cited by 31
Murry, J. P., Higgins, J., Matthews, T. B., Huang, V. Y., Rompay, K. K. A. V., Pedersen, N. C., & North, T. W. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1120-1130.2003 · Cited by 30
“This M184V mutation is located in the highly conserved YMDD motif of RT, which is directly involved in binding the incoming nucleotide during reverse transcription (19, 20, 24, 53).”
BackgroundEfavirenz: shifting the HAART paradigm in adult HIV-1 infection
Moyle, G. J. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.4.473 · Cited by 29
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Clercq, E. D. (1994) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.3.3.253 · Cited by 29
Pungpo, P., & Hannongbua, S. (2000) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(00)00053-x · Cited by 29
A DNA-hairpin model for repeat-addition processivity in telomere synthesis
Yang, W., & Lee, Y. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3098 · Cited by 28
Synergistic Interactions between Hepatitis B Virus RNase H Antagonists and Other Inhibitors
Lomonosova, E. E., Zlotnick, A., & Tavis, J. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02441-16 · Cited by 28
Li, W., Li, X., Clercq, E. D., Zhan, P., & Liu, X. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.07.043 · Cited by 30
Buckheit, R. W., Hartman, T. L., Watson, K. M., Chung, S.-G., & Cho, E.-H. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00972-07 · Cited by 30
“Two classes of RT inhibitors are currently marketed—nonnucleoside RT inhibitors (NNRTIs) and nucleoside or nucleotide RT inhibitors (NRTIs or NtRTIs) (15, 16, 19, 22, 27).”
BackgroundBeilhartz, G. L., Ngure, M., Johns, B. A., DeAnda, F., Gerondelis, P., & Götte, M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.569707 · Cited by 28
“The distance between the polymerase and RNase H active sites is 60 Å (3, 4, 7).”
BackgroundEl‐Brollosy, N. R., Al‐Deeb, O. A., El-Emam, A. A.-R., Pedersen, E. B., Colla, P. L., Collu, G., Sanna, G., & Loddo, R. (2009) · Archiv der Pharmazie · doi:10.1002/ardp.200900139 · Cited by 28
Sun, D., Jessen, S. M., Liu, C., Liu, X., Najmudin, S., & Georgiadis, M. M. (1998) · Protein Science · doi:10.1002/pro.5560070711 · Cited by 31
A BATTLE AGAINST AIDS: NEW PYRAZOLE KEY TO AN OLDER LOCK-REVERSE TRANSCRIPTASE
Sony Jacob, K., & Ganguly, S. (2016) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2016v8i11.12634 · Cited by 28
“Examples include nevirapine, delavirdine, efavirenz, etravirine, and rilpivirine [4].”
BackgroundChapter 13. Advances in the Development of HIV Reverse Transcriptase Inhibitors
Romero, D. L. (1994) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60726-5 · Cited by 30
Petrella, M., Oliveira, M., Moisi, D. D., Detorio, M., BRENNER, B. G., & Wainberg, M. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4189-4194.2004 · Cited by 30
[25] Analysis of inhibition of retroviral reverse transcriptase
Balzarini, J. M., & Clercq, E. D. (1996) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(96)75027-9 · Cited by 28
Schinazi, R. F., Lloyd, R. M., Ramanathan, C. S., & Taylor, E. W. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.268 · Cited by 32
“free energy RNA secondary structure for the HIV-1 RTcoding regions corresponding to the finger, palm, and thumb domains of the RT crystal structure (17), shown as base numbers 1 to 972 on the abscissa, equivalent to the HIV-1 sequence from positions 2132 to 3103 (42).”
BackgroundNew Antiviral Agents for the Therapy of Chronic Hepatitis B Virus Infection
Zoulim, F., & TREPO, C. G. (1999) · Intervirology · doi:10.1159/000024972 · Cited by 31
Argyris, E. G., Vanderkooi, J. M., Venkateswaran, P. S., Kay, B. K., & Paterson, Y. Y. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1549 · Cited by 29
Nucleoside Reverse Transcriptase Inhibitors And Resistance Of Human Immunodeficiency Virus Type 1
Johnson, V. A. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.supplement_2.s140 · Cited by 29
“Intense efforts also are underway to identify the structurefunction relationships of drug-resistant mutant viruses with regard to their impact on available RT crystalline structure data [93, 94] and their effect on enzyme function as determined by biochemical analyses [5, 78, 82, 85, 86, 91, 9598].”
BackgroundRandolph, C., & Champoux, J. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32154-3 · Cited by 28
HIV-1 reverse transcriptase: Inhibition by 2',5'-oligoadenylates
Sobol, R. W., Fisher, W., Reichenbach, N. L., Kumar, A., Beard, W. A., Wilson, S. H., Charubala, R., Pfleiderer, W., & Suhadolnik, R. J. (1993) · Biochemistry · doi:10.1021/bi00096a023 · Cited by 28
Energetics of Mutation-Induced Changes in Potency of Lersivirine against HIV-1 Reverse Transcriptase
Kar, P., & Knecht, V. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp300818c · Cited by 27
Hull, R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384871-0.00007-8 · Cited by 28
“The crystal structures of RNA replicases and RT do not reveal the 5′-3′ exonucleolytic proofreading domain present in DNA-dependent DNA polymerases (Kohlstaedt et al., 1992; Joyce and Steitz, 1994; Hansen et al., 1997) .”
BackgroundKudalkar, S. N., Ullah, I., Bertoletti, N., Mandl, H. K., Cisneros, J. A., Beloor, J., Chan, A. H., Quijano, E., Saltzman, W. M., Jorgensen, W. L., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.04.010 · Cited by 27
Kissel, J. D., Held, D. M., Hardy, R. W., & Burke, D. H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm420 · Cited by 29
A Novel Retron That Produces RNA-less msDNA inEscherichia coliUsing Reverse Transcriptase
Lima, T. M. O., & Lim, D. (1997) · Plasmid · doi:10.1006/plas.1997.1298 · Cited by 27
Biondi, M. J., Beilhartz, G. L., McCormick, S. U., & Götte, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.105775 · Cited by 30
Evolution of diffraction methods for solving crystal structures
Hendrickson, W. A. (2012) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767312050453 · Cited by 31
“The HIV pandemic led to several significant structural projects including its protease (Navia et al., 1989) and reverse transcriptase (Kohlstaedt et al., 1992), which facilitated drug discoveries that can keep the disease in check, and its envelope glycoprotein (Kwong et al., 1998), which has…”
BackgroundSmith, R. A., Remington, K. M., Preston, B. D., Schinazi, R. F., & North, T. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2335-2340.1998 · Cited by 35
Fidelity of Nucleotide Incorporation by the RNA-Dependent RNA Polymerase from Poliovirus
Cameron, C. E., Moustafa, I. M., & Arnold, J. J. (2016) · The Enzymes · doi:10.1016/bs.enz.2016.02.002 · Cited by 28
HIV-1 Reverse Transcriptase: A Metamorphic Protein with Three Stable States
London, R. E. (2019) · Structure · doi:10.1016/j.str.2018.11.011 · Cited by 29
“…uthor M anuscript A uthor M anuscript Among the earliest metamorphic proteins characterized, HIV-1 reverse transcriptase (RT) remains unique in that two alternately folded forms of the polymerase domain are both present in the p66/p51 RT heterodimer (Kohlstaedt et al., 1992; Wang et al., 1994).”
BackgroundThomas, D. C., Veaute, X., Fuchs, R. P., & Kunkel, T. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.21226 · Cited by 29
“…polymerases are not yet known, some information does exist for Klenow DNA polymerase (Joyce and Steitz, 1994), human immunodeficiency virus type 1 reverse transcriptase (Kohlstaedt et al., 1992; JacoboMolina et al., 1993), T7 RNA polymerase (Sousa et al., 1993), and pol b (Pelletier et al., 1994).”
BackgroundBurnett, B. P., & McHenry, C. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7210 · Cited by 32
Magnetic Interaction in Dinuclear Triphos−Cobalt Complexes with Co···Co Separations of 8 and 10 Å
Heinze, K., Hüttner, G., & Schober, P. (1998) · European Journal of Inorganic Chemistry · doi:10.1002/(sici)1099-0682(199802)1998:2<159::aid-ejic159>3.0.co;2-d · Cited by 9
Identification of Conserved Residues Contributing to the Activities of Adenovirus DNA Polymerase
Liu, H., Naismith, J. H., & Hay, R. T. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11681-11689.2000 · Cited by 34
“The catalytic center has been visualized, and most of the conserved residues are located at or near this center (12, 19, 27, 33, 34, 36, 37, 43, 53, 55), although the structural framework that supports this arrangement of conserved residues varies considerably.”
BackgroundRichman, D. D. (1994) · Trends in Microbiology · doi:10.1016/0966-842x(94)90619-x · Cited by 31
Gopalakrishnan, V., & Benkovic, S. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41750-9 · Cited by 33
Lin, S., Long, S., Kalb, S. R., Cotter, R. J., & Woods, A. S. (2000) · Analytical Chemistry · doi:10.1021/ac991429f · Cited by 27
Tanaka, M., Srinivas, R. V., Ueno, T., Kavlick, M. F., Hui, F. K., Fridland, A., Driscoll, J. S., & Mitsuya, H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1313 · Cited by 30
“1 20 1 5 (13) 2–3 60 2 4–7 100 4 8 120 2 9–13 150 5 14–17 200 5 18 200 1 20 (43)”
BackgroundEVOLUTIONARY BIOLOGY OF HUMAN IMMUNODEFICIENCY VIRUS
Brown, A., & Holmes, E. C. (1994) · Annual Review of Ecology and Systematics · doi:10.1146/annurev.es.25.110194.001015 · Cited by 27
The development of resistance of HIV-1 to zalcitabine
Craig, C., & Moyle, G. J. (1997) · AIDS · doi:10.1097/00002030-199703110-00003 · Cited by 28
Development of Anti-HIV Therapeutics: From Conventional Drug Discovery to Cutting-Edge Technology
Sun, Y., & Wang, L. (2024) · Pharmaceuticals · doi:10.3390/ph17070887 · Cited by 30
“NNRTIs are small hydrophobic compounds that bind to an allosteric site located approximately 10 Å away from the RT catalytic active site to inhibit DNA polymerization [54].”
BackgroundEndogenous retrovirus expression in testis and epididymis
Crowell, R. C., & Kiessling, A. A. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350629 · Cited by 28
Santos, L. H., Ferreira, R. S., & Caffarena, E. R. (2015) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150239 · Cited by 32
“However, p51 lacks the catalytic activity and the RNase H domain, performing a structural role (Kohlstaedt et al. 1992).”
BackgroundNizami, B., Sydow, D., Wolber, G., & Honarparvar, B. (2016) · Molecular BioSystems · doi:10.1039/c6mb00428h · Cited by 26
Two-Metal-Ion Catalysis: Inhibition of DNA Polymerase Activity by a Third Divalent Metal Ion
Wang, J., & Konigsberg, W. H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.824794 · Cited by 30
“In 1992 Thomas Steitz and others published the second DNA polymerase structure, HIV-1 RT in complex with an inhibitor, and suggested that all DNA polymerases exhibit a hand-like architecture and have highly conserved carboxylates for binding of two metal ions (Kohlstaedt et al., 1992).”
BackgroundSelf-citationFactors affecting the dimerization of the p66 form of HIV‐1 reverse transcriptase
Cabodevilla, J. F., Odriozola, L., Santiago, E., & Martínez-Irujo, J. J. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01939.x · Cited by 26
“Whereas the p66 subunit adopts an `open' catalytically competent conformation that can accommodate the RNA/DNA template, the p51 is `closed' and is assumed to play a largely structural role in the RT heterodimer [2].”
BackgroundMechanisms of Hepatitis B Virus Resistance Development
Warner, N., & LOCARNINI, S. A. (2014) · Intervirology · doi:10.1159/000360940 · Cited by 29
Reverse transcriptase and integrase of the Saccharomyces cerevisiae Ty1 element
Wilhelm, F. X., Wilhelm, M. L., & Gabriel, A. (2005) · Cytogenetic and Genome Research · doi:10.1159/000084960 · Cited by 28
“…distance between the positions of RNase H cleavage and DNA polymerase active sites is 18– 20 bp (Wöhrl and Moelling, 1990; Furfine and Reardon, 1991; Gopalakrishnan et al., 1992; Kati et al., 1992; Kohlstaedt et al., 1992; Jacobo-Molina et al., 1993; Götte et al., 1995, 1999; Huang et al., 1998).”
BackgroundKinetics of Association and Dissociation of HIV-1 Reverse Transcriptase Subunits
Venezia, C. F., Meany, B. J., Braz, V. A., & Barkley, M. D. (2009) · Biochemistry · doi:10.1021/bi9010495 · Cited by 29
“effects, and (3) conformational selection.”
BackgroundA Mg2+‐induced conformational switch rendering a competent DNA polymerase catalytic complex
Mendieta, J., Cases‐González, C. E., Matamoros, T., Ramírez, G., & Menéndez‐Arias, L. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21711 · Cited by 29
Use of pair potentials across protein interfaces in screening predicted docked complexes
Moont, G., Gabb, H. A., & Sternberg, M. J. E. (1999) · Proteins: Structure, Function, and Genetics · doi:10.1002/(sici)1097-0134(19990515)35:3<364::aid-prot11>3.0.co;2-4 · Cited by 255
Spallarossa, A., Cesarini, S., Ranise, A., Bruno, O., Schenone, S., Colla, P. L., Collu, G., Sanna, G., Secci, B., & Loddo, R. (2008) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.09.024 · Cited by 26
Liu, W., Shi, X., & Gong, P. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky848 · Cited by 26
“The encirclement created by the interactions between the finger tips and thumb makes the distinction from other right-hand polymerases such as the klenow fragment of DNA polymerase I, the bacteriophage T7 RNA polymerase and the human immunodeficiency virus 1 reverse transcriptase (HIV-1 RT) (17–19).”
Yoakim, C., Bonneau, P. R., Déziel, R., Doyon, L., Duan, J., Guse, I., Landry, S. R., Malenfant, É., Naud, J., Ogilvie, W. W., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.11.049 · Cited by 26
Bellarosa, D., Antonelli, G., Bambacioni, F., Giannotti, D., Viti, G., Nannicini, R., Giachetti, A., DIANZANI, F., Witvrouw, M., & Pauwels, R. (1996) · Antiviral Research · doi:10.1016/0166-3542(95)00906-x · Cited by 26
Misra, H. S., Pandey, P. K., & Pandey, V. N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9785 · Cited by 29
Dufour, E., Reinbolt, J., Castroviejo, M., Ehresmann, B., Litvak, S., Tarrago‐Litvak, L., & Andréola, M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2430 · Cited by 33
Inhibition of HIV-1 reverse transcription: basic principles of drug action and resistance
Götte, M. (2004) · Expert Review of Anti-infective Therapy · doi:10.1586/14789072.2.5.707 · Cited by 26
McWilliams, M. J., Julias, J. G., Sarafianos, S. G., Alvord, W. G., Arnold, E., & Hughes, S. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11150-11157.2003 · Cited by 29
“Based on the crystal structure, the polymerase domain of HIV-1 RT has been likened to a right hand, composed of fingers, palm, thumb, and connection subdomains (14).”
BackgroundMethodHalvas, E. K., Svarovskaia, E. S., & Pathak, V. K. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.312-319.2000 · Cited by 27
“Structural similarities between murine leukemia virus (MLV) and HIV-1 RTs suggests that understanding the structural determinants of MLV RT important for fidelity may provide insights into the fidelity of HIV-1 RT (22, 38).”
BackgroundWhat can oncologists learn from HIV?
Stebbing, J., & Bower, M. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01142-2 · Cited by 28
Fletcher, R. S., Arion, D., Borkow, G., Wainberg, M. A., Dmitrienko, G. I., & Parniak, M. A. (1995) · Biochemistry · doi:10.1021/bi00032a002 · Cited by 26
Craig, J. C., Whittaker, L., Duncan, I. B. R., & Roberts, N. A. (1994) · Antiviral chemistry & chemotherapy · doi:10.1177/095632029400500605 · Cited by 27
Clinical Significance of Drug Resistance in Human Immunodeficiency Virus
Richman, D. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.supplement_2.s166 · Cited by 27
“35 nm has been made by complexing the reverse transcriptase heterodimer with the NNRTI nevirapine [24].”
MethodPhysical mapping of HIV reverse transcriptase to the 5′ end of RNA primers
DeStefano, J. J., Cristofaro, J. V., Derebail, S., Bohlayer, W. P., & Fitzgerald-Heath, M. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103958200 · Cited by 25
The p66 immature precursor of HIV-1 reverse transcriptase
Sharaf, N. G., Poliner, E., Slack, R. L., Christen, M. T., Byeon, I. L., Parniak, M. A., Gronenborn, A. M., & Ishima, R. (2014) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24594 · Cited by 25
Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants
Smith, S. J., Pauly, G. T., Akram, A., Melody, K., Rai, G., Maloney, D. J., Ambrose, Z., Thomas, C. J., Schneider, J. T., & Hughes, S. H. (2016) · Retrovirology · doi:10.1186/s12977-016-0244-2 · Cited by 29
“The second class consists of inhibitors that bind in a small hydrophobic pocket ~10 Å from the polymerase active site (non-nucleoside reverse transcriptase inhibitors, NNRTIs) [2–4].”
BackgroundBrandt, P., Geitmann, M., & Danielson, U. H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101052g · Cited by 25
Metadata
- Authors
- Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1992-06-26
- Volume
- 256
- Issue
- 5065
- Pages
- 1783-1790
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008954911
- Cited by
- 1,914
- References
- 67
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 29 · 2020: 18 · 2019: 24 · 2018: 37 · 2017: 39 · 2016: 39 · 2015: 38 · 2014: 44 · 2013: 63 · 2012: 42
- FWCI
- 128.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm039546-10)
- National Institute of General Medical Sciences (GM 39546)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 reverse transcriptase, nevirapine, drug resistance, polymerase domain, asymmetric dimer, RNase H, RNA-DNA hybrids, active site, protein-inhibitor complex
- MeSH terms
- Azepines, Binding Sites, Crystallography, DNA Polymerase I, Escherichia coli, Models, Molecular, Protein Conformation, Pyridines, RNA-Directed DNA Polymerase, Molecular Structure, HIV-1, Nevirapine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.